Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 996 | 993 | 1,034 | 1,097 | 1,301 | 1,359 | 1,339 | 1,404 | 1,571 | 1,707 | 1,910 | 1,940 |
| Expenses | 968 | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,639 | 1,824 | 1,844 |
| Operating Profit | 29 | 29 | 29 | 30 | 42 | 50 | 49 | 50 | 62 | 68 | 86 | 97 |
| OPM % | 2.9% | 2.9% | 2.8% | 2.8% | 3.3% | 3.7% | 3.6% | 3.6% | 4.0% | 4.0% | 4.5% | 5% |
| Other Income | 2 | 2 | 9 | 13 | 11 | 8 | 7 | 6 | 5 | -4 | 4 | 3 |
| Interest | 18 | 16 | 17 | 10 | 11 | 10 | 10 | 11 | 12 | 14 | 17 | 21 |
| Depreciation | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 | 10 | 15 | 12 |
| Profit before tax | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 | 45 | 40 | 58 | 67 |
| Tax % | 23% | 16% | -56% | 25% | 25% | 25% | 16% | 17% | 18% | 16% | 22% | 22% |
| Net Profit | 5 | 7 | 21 | 21 | 26 | 29 | 31 | 30 | 37 | 34 | 45 | 52 |
| EPS in Rs | 3.19 | 4.22 | 4.82 | 4.62 | 5.43 | 5.85 | 5.90 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,350 | 1,773 | 2,522 | 3,300 | 3,922 | 5,096 | 6,591 | 7,128 |
| Expenses | 1,326 | 1,758 | 2,498 | 3,236 | 3,810 | 4,924 | 6,325 | 6,815 |
| Operating Profit | 23 | 15 | 24 | 64 | 112 | 172 | 266 | 313 |
| OPM % | 1.7% | 0.8% | 1.0% | 1.9% | 2.9% | 3.4% | 4.0% | 4.4% |
| Other Income | 5 | 11 | 4 | 6 | 14 | 39 | 11 | 8 |
| Interest | 13 | 20 | 29 | 49 | 66 | 42 | 54 | 64 |
| Depreciation | 12 | 16 | 20 | 24 | 25 | 31 | 43 | 47 |
| Profit before tax | 4 | -11 | -20 | -4 | 36 | 139 | 179 | 210 |
| Tax % | 67% | 42% | 49% | 201% | -12% | 23% | 19% | |
| Net Profit | 1 | -15 | -29 | -11 | 40 | 107 | 146 | 168 |
| EPS in Rs | 93.81 | -1,550.90 | -77.71 | -28.12 | 8.99 | 21.79 | 26.44 | 28.82 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 30% | 26% | 32% | ||
| Compounded Profit Growth | % | 57% | 130% | 26% | ||
| Stock Price CAGR | % | % | % | 58% | ||
| Return on Equity | % | % | 6% | 7% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 4 | 4 | 43 | 44 | 44 |
| Reserves | -16 | -32 | -62 | -73 | 1,595 | 1,681 | 1,645 |
| Borrowings | 603 | 720 | 974 | 1,101 | 338 | 385 | 677 |
| Other Liabilities | 162 | 147 | 210 | 275 | 369 | 593 | 1,234 |
| Total Liabilities | 749 | 836 | 1,125 | 1,308 | 2,345 | 2,703 | 3,600 |
| Fixed Assets | 186 | 189 | 262 | 268 | 289 | 559 | 958 |
| CWIP | 2 | 2 | 1 | 0 | 0 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 58 | 130 |
| Other Assets | 560 | 645 | 863 | 1,040 | 2,056 | 2,085 | 2,510 |
| Total Assets | 749 | 836 | 1,125 | 1,308 | 2,345 | 2,703 | 3,600 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -37 | -69 | -35 | -45 | -37 | -77 | 96 |
| Cash from Investing Activity | -203 | -31 | -162 | -49 | -704 | 232 | -302 |
| Cash from Financing Activity | 217 | 89 | 211 | 73 | 863 | -74 | 124 |
| Net Cash Flow | -23 | -11 | 14 | -21 | 122 | 82 | -82 |
| Free Cash Flow | -81 | -78 | -45 | -51 | -41 | -87 | 29 |
| CFO/OP | -134% | -430% | -100% | -51% | -21% | -23% | 56% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 50 | 54 | 57 | 57 | 59 | 67 |
| Inventory Days | 57 | 54 | 49 | 41 | 43 | 52 | 52 |
| Days Payable | 32 | 22 | 22 | 25 | 24 | 31 | 45 |
| Cash Conversion Cycle | 88 | 82 | 81 | 73 | 77 | 80 | 74 |
| Working Capital Days | 57 | 54 | 41 | 32 | 48 | 65 | 35 |
| ROCE % | 1% | 1% | 5% | 7% | 9% | 10% |
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 52.44% | 52.44% | 52.44% | 52.44% | 52.42% | 52.42% | 52.42% | 52.42% | 52.42% | 52.40% |
| FIIs | 23.30% | 23.32% | 23.82% | 22.20% | 19.92% | 17.21% | 14.68% | 5.14% | 4.03% | 4.36% |
| DIIs | 2.28% | 2.06% | 7.73% | 8.78% | 9.63% | 10.19% | 9.64% | 16.42% | 16.62% | 15.48% |
| Public | 21.99% | 22.18% | 16.02% | 16.59% | 18.03% | 20.19% | 23.26% | 26.03% | 26.94% | 27.77% |
| No. of Shareholders | 80,864 | 66,400 | 36,767 | 33,172 | 33,159 | 33,338 | 36,334 | 40,333 | 39,084 | 39,709 |
Fundamentals
Market Cap₹ 7,681 Cr.
Current Price₹ 1,765
Stock P/E59.5
Book Value₹ 388
ROCE10.5 %
ROE6.94 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)32%
Compounded Profit Growth (TTM)26%
Consolidated figures.
Valuation
Market capRs 7,315 Cr
Enterprise valueRs 8,310 Cr
P/E (TTM)58.34x
Price to book-106.65x
Price to sales1.03x
EV / EBITDA25.88x
EV / EBIT30.29x
EV / sales1.17x
Earnings yield1.71%
Profitability
Operating margin (excl. other income)1.94%
Operating margin (incl. other income)2.11%
EBITDA margin4.51%
Pre-tax margin2.95%
Net profit margin1.76%
Net margin, latest quarter1.97%
ROE18.27%
ROCE4.65%
ROA-0.95%
ROE, 3-year average50.01%
ROCE, 3-year average2.41%
ROA, 3-year average-1.99%
ROIC (approx.)89.22%
Tax rate-201.08%
Other income / net worth-8.03%
Growth
Sales growth (latest year)30.85%
Sales CAGR, 3 years34.72%
Sales growth QoQ1.60%
Profit growth QoQ36.24%
Sales growth YoY (latest quarter)38.23%
Profit growth YoY (latest quarter)37.27%
Per share
EPS (TTM)Rs 28.81
EPS (latest year)Rs -28.12
EPS (latest quarter)Rs 8.77
EPS, 3-year averageRs -552.24
Book value per shareRs -15.76
Sales per shareRs 1,637.73
Cash flow per shareRs -10.41
Free cash flow per shareRs 6.66
Efficiency
Asset turnover2.52x
Fixed asset turnover12.33x
Inventory turnover8.90x
Inventory days41 days
Debtor days57 days
Debtors turnover6.41x
Creditor days45 days
Cash conversion cycle74 days
Working capital days35 days
Leverage
Total debtRs 1,101 Cr
Cash and bankRs 107 Cr
Net debtRs 995 Cr
Debt to equity-16.06x
Net debt / EBITDA3.10x
Interest coverage4.27x
Current ratio (filing 2026-03-31)1.58x
Quick ratio (filing 2026-03-31)1.05x
Trade payables (filing 2026-03-31)Rs 725 Cr
Owners' fund to total sources-5.24%
Debt to assets84.20%
Cash flow
Cash from Operating Activity (latest year)Rs -45 Cr
Cash from Investing Activity (latest year)Rs -49 Cr
Cash from Financing Activity (latest year)Rs 73 Cr
Net Cash Flow (latest year)Rs -21 Cr
Free cash flow (latest year)Rs 29 Cr
FCFE (approx.: FCF + change in debt)Rs 157 Cr
Cash from ops / profit, 5 years-0.39x
Statement figures
Net sales (TTM)Rs 7,128 Cr
Net sales (latest year)Rs 3,300 Cr
Sales (latest quarter)Rs 1,940 Cr
Operating profit excl. other income (latest year)Rs 64 Cr
Operating profit (latest quarter)Rs 97 Cr
Other income (TTM)Rs 8 Cr
EBITDA (TTM)Rs 321 Cr
PBDT (TTM)Rs 257 Cr
Profit before tax (TTM)Rs 210 Cr
Tax (latest year)Rs 7 Cr
Net profit (TTM)Rs 125 Cr
Net profit (latest year)Rs -12 Cr
Net profit (latest quarter)Rs 38 Cr
Depreciation (TTM)Rs 47 Cr
Depreciation (latest quarter)Rs 12 Cr
Interest (TTM)Rs 64 Cr
Cost of goods sold (latest year)Rs 3,040 Cr
Total expenditure (latest year)Rs 3,236 Cr
Total income (latest year)Rs 3,306 Cr
Share capitalRs 4 Cr
ReservesRs -73 Cr
Shareholders' fundsRs -69 Cr
Total assetsRs 1,308 Cr
Net blockRs 268 Cr
ReceivablesRs 515 Cr
InventoryRs 342 Cr
Other liabilitiesRs 275 Cr
Shares outstanding (crore)4.35
Ownership
Promoter holding52.40% (-0.02 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | ENTERO | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -9.3% | -2.8% | -6.5 pts |
| 1 month | -6.9% | -6.8% | -0.1 pts |
| 3 months | +38.6% | -7.6% | +46.3 pts |
| 6 months | +34.7% | +0.4% | +34.3 pts |
| 1 year | +52.1% | -9.9% | +62.0 pts |
| 2 years | +17.2% | -13.6% | +30.8 pts |
22 mutual fund schemes hold about ₹619 Cr.
Over three months 10 bought more and 7 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Invesco India Contra Fund | 1.14% | 235 | -12% |
| ICICI Pru Healthcare Fund- | 1.23% | 86 | -47% |
| Bank of India Flexi Cap Fund | 2.43% | 72 | -3% |
| Bank of India Multi Cap Fund | 3.60% | 48 | +37% |
| Bank of India Small Cap Fund | 1.13% | 37 | -15% |
| Invesco India ELSS Tax Saver Fund | 1.21% | 33 | -11% |
| Motilal Oswal Innovation Opportunities Fund | 3.42% | 24 | +511% |
| HSBC Consumption Fund | 1.01% | 18 | +3% |
| Bank of India Large & Mid Cap Fund | 2.95% | 16 | +55% |
| Bank of India Consumption Fund | 4.03% | 15 | +20% |
| Invesco India Aggressive Hybrid Fund | 1.17% | 9 | -11% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 0.31% | 8 | +2% |
| Bank of India Multi Asset Allocation Fund | 1.79% | 7 | +100% |
| Edelweiss Consumption Fund | 1.09% | 5 | +100% |
| Invesco India Equity Savings Fund | 0.65% | 2 | -32% |
| Invesco India Equity Savings Fund | 0.65% | 2 | -32% |
| Bank of India Large Cap Fund | 0.64% | 1 | +100% |
| Groww Nifty Total Market Index Fund | 0.01% | 0 | +12% |
| Angel One Nifty Total Market Index Fund | 0.01% | 0 | +1% |
| Mirae Asset Nifty Total Market Index Fund | 0.01% | 0 | +12% |
| Bandhan Nifty Total Market Index Fund | 0.01% | 0 | +1% |
| Motilal Oswal BSE 1000 Index Fund | 0.01% | 0 | +12% |
Red flags
F-score 4 of 8| serious | Negative equity Shareholders' equity is negative |
| explain | Share dilution Share count up 5% in a year, 4000% in three |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Insider trades
NSE insider and takeover-code disclosures| Date | Who | Role | Side | Shares | Value | How |
|---|---|---|---|---|---|---|
| 2026-09-18 | Prasid Uno Family Trust | Acquirer | sell | 2,130,000 | SAST Others |
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.
Latest quarter
Jun 2026Sales ₹1,940 Cr +38.2% vs Jun 2025.
Net profit ₹52 Cr +73.3%.
Against our estimate for Jun 2026: sales +3.0%, profit +22.9% beat. Our estimate for Sep 2026: sales Rs 2,206 Cr, profit Rs 52 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Medplus Health Services Ltd | 7,857 | 37.3 | 12.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Entero Healthcare Solutions Ltd?
Entero Healthcare Solutions Ltd (ENTERO) has a market capitalisation of Rs 7,681 Cr. at the 2026-10-01 close.
What is the P/E ratio of Entero Healthcare Solutions Ltd?
Entero Healthcare Solutions Ltd trades at a P/E of 59.5 on trailing twelve-month profit, at the 2026-10-01 close.
What were Entero Healthcare Solutions Ltd's latest quarterly results?
In the Jun 2026 quarter, Entero Healthcare Solutions Ltd sales was Rs 1,940 Cr (+38.2% vs Jun 2025) and net profit was Rs 52 Cr.
What is the 52-week high and low of Entero Healthcare Solutions Ltd?
The 52-week high is Rs 1,920.00 and the 52-week low is Rs 944.00.